Muscarinic receptor modulation of basal and β-adrenergic stimulated function of the failing human left ventricle

Journal of Clinical Investigation

Volumn 98, Issue 12, 1996, Pages 2756-2763

  Newton, Gary E ^a   Parker, Andrea B ^b   Landzberg, Joel S ^c   Colucci, Wilson S ^c   Parker, John D ^a,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b SOCAR RESEARCH SA   (Switzerland)

^c HARVARD MEDICAL SCHOOL   (United States)

^d MOUNT SINAI HOSPITAL   (Canada)

Author keywords

acetylcholine; atropine; diastole; dobutamine; heart failure, congestive

Indexed keywords

ACETYLCHOLINE; ATROPINE; DOBUTAMINE; MUSCARINIC RECEPTOR;

ADRENERGIC RECEPTOR BLOCKING; ADULT; ARTICLE; BETA ADRENERGIC STIMULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HUMAN; HUMAN CELL; HUMAN TISSUE; INOTROPISM; INTRACARDIAC DRUG ADMINISTRATION; INTRACORONARY INFUSION; LUNG VENTILATION PERFUSION RATIO; MALE; PRIORITY JOURNAL;

EID: 0030482195     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119101     Document Type: Article

References (38)

1. Eckberg, D.L., M. Drabinsky, and E. Braunwald. 1971. Defective cardiac parasympathetic control in patients with heart disease. N. Engl. J. Med. 285: 877-883.
2. Porter, T.R., D.L. Eckberg, J.M. Fritsch, R.F. Rea, L.A. Beightol, J.F. Schmedtje, and P.K. Mohanty. 1990. Autonomic pathophysiology in heart failure patients. Sympathetic-cholinergic interrelations. J. Clin. Invest. 85:1362-1371.
3. De Ferrari, G.M., E. Vanoli, P. Curcuruto, G. Tommasini, and P.J. Schwartz, 1992. Prevention of life-threatening arrhythmias by pharmacologic stimulation of the muscarinic receptors with oxotremorine. Am. Heart. J. 124: 883-890.
4. La Rovere, M.T., A. Mortara, P. Pantaleo, R. Maestri, F. Cobelli, and L. Tavazzi. 1994. Scopolamine improves autonomic balance in advanced congestive heart failure. Circulation. 90:838-843.
5. 1 during pacing induced heart failure. Circulation. 94:102-107.
6. Levy, M.N., and B. Blattberg. 1976. Effect of vagal stimulation on the overflow of norepinephrine into the coronary sinus during cardiac sympathetic nerve stimulation in the dog. Circ. Res. 38:81-85.
7. Henning, R.J., I.R. Khalil, and M.N. Levy. 1990. Vagal stimulation attenuates sympathetic enhancement of left ventricular function. Am. J. Physiol. 258: H1470-H1475.
8. Hare, J.M., J.F. Keaney, J.L. Balligand, J. Loscalzo, T.W. Smith, and W.S. Colucci. 1995. Role of nitric oxide in parasympathetic modulation of β-adrenergic myocardial contractility in normal dogs. J. Clin. Invest. 95:360-366.
9. Landzberg, J.S., J.D. Parker, D.F. Gauthier, and W.S. Colucci. 1994. Effect of intracoronary acetylcholine and atropine on basal and dobutamine-stimulated left ventricular contractility. Circulation. 89:164-168.
10. Vatner, D.E., D.L. Lee, K.R. Schwarz, J.P. Longabaugh, A.M. Fujii, S.F. Vatner, and C.J. Homcy. 1988. Impaired cardiac muscarinic receptor function in dogs with heart failure. J. Clin. Invest. 81:1836-1842.
11. 2+ channels in experimental cardiac failure. Am J. Physiol. 261:H1979-H1987.
12. 2-muscarinic receptors increase in the canine pacing-overdrive model of heart failure. Can. J. Cardiol. 11:71-76.
13. Bristow, M.R. 1993. Changes in myocardial and vascular receptors in heart failure. J. Am. Coll. Cardiol. 22:61A-71A.
14. Bohm, M., M. Ungerer, and E. Erdmann. 1990. Beta adrenoceptors and m-cholinoceptors in myocardium of hearts with coronary artery disease or idiopathic dilated cardiomyopathy removed at cardiac transplantation. Am. J. Cardiol. 66:880-882.
15. ia in human hearts with dilated but not ischemic cardiomyopathy. Circulation. 82:1249-1265.
16. Feldman, A.M., A.E. Cates, W.B. Veazey, R.E. Hershberger, M.R. Bristow, K.L. Baughman, W.A. Baumgartner, and C. Van Dop. 1988. Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart. J. Clin. Invest. 82:189-197.
17. 1-Adenosine receptor inhibition of adenylate cyclase activity in failing and nonfailing human ventricular myocardium. Circulation. 83:1343-1351.
18. -2 in human end-stage heart failure. Circ. Res. 70:688-696.
19. Henning, R.J., J. Cheng, and M.N. Levy. 1989. Vagal stimulation decreases rate of left ventricular relaxation. Am. J. Physiol. 256:H428-H433.
20. Xenopoulos, N.P., and R.J. Applegate. 1994. The effect of vagal stimulation on left ventricular systolic and diastolic performance. Am. J. Physiol. 266: H2167-H2173.
21. Weiss, J.L., J.W. Frederiksen, and M.L. Weisfeldt. 1976. Hemodynamic determinants of the time-course of fall in canine left ventricular pressure. J. Clin. Invest. 58:751-760.
22. Mirsky, I. 1984. Assessment of diastolic function: suggested methods and future considerations. Circulation. 69:836-841.
23. Floras, J.S. 1993. Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure. J. Am. Coll. Cardiol. 22:72A-84A.
24. Parker, J.D., J.S. Landzberg, J.A. Bittl, I. Mirsky, and W.S. Colucci. 1991. Effects of β-adrenergic stimulation with dobutamine on isovolumic relaxation in the normal and failing left ventricle. Circulation. 84:1040-1048.
25. Fleming, J.W., R.A. Strawbridge, and A.M. Watanabe. 1987. Muscarinic receptor regulation of cardiac adenylate cyclase activity. J. Mol. Cell. Cardiol. 19:47-61.
26. Muscholl, E. 1980. Peripheral muscarinic control of norepinephrine release in the cardiovascular system. Am. J. Physiol. 239:H713-H720.
27. Meredith, I.T., G. Eisenhofer, G.W. Lambert, E.M. Dewar, G.L. Jennings, and M.D. Esler. 1993. Cardiac sympathetic nervous activity in congestive heart failure: evidence for increased neuronal norepinephrine release and preserved neuronal uptake. Circulation. 88:136-145.
28. 2+ current in single heart cells. Circ. Res. 29:437-445.
29. Levy, M.N. 1971. Sympathetic-parasympathetic interactions in the heart. Circ. Res. 29:437-445.
30. Gupta, R.C., J. Neumann, and A.M. Watanabe. 1993. Comparison of adenosine and muscarinic receptor-mediated effects on protein phosphatase inhibitor-1 activity in the heart. J. Pharmacol. Exp. Ther. 266:16-22.
31. Arai, M., N.R. Alpert, D.H. Maclennan, P. Barton, and M. Periasamy. 1993. Alterations in sarcoplasmic reticulum gene expression in human heart failure: a possible mechanism for alterations in systolic and diastolic properties of the failing myocardium. Circ. Res. 72:463-469.
32. Paulus, W.J., P.J. Vantrimpont, and A.M. Shah. 1994. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Circulation. 89:2070-2078.
33. Colucci, W.S., A.R. Denniss, G.F. Leatherman, R.J. Quigg, P.J. Ludmer, J.D. Marsh, and D.F. Gauthier. 1988. Intracoronary infusion of dobutamine to patients with and without severe congestive heart failure. J. Clin. Invest. 81:1103-1110.
34. Varma, S.K., R.M. Owen, M.L. Smucker, and M.D. Feldman. 1989. Is t a preload-independent measure of isovolumetric relaxation? Circulation. 80: 1757-1765.
35. Starling, M.R., D.G. Montgomery, G.B.J. Mancini, and R.A. Walsh. 1987. Load independence of the rate of isovolumic relaxation in man. Circulation. 76:1274-1281.
36. Blaustein, A.S., and W.H. Gaasch. 1983. Myocardial relaxation. VI. Effects of β-adrenergic tone and asynchrony on LV relaxation rate. Am. J. Physiol. 244:H417-H422.
37. Jaski, B.E., M.A. Fifer, R.F. Wright, E. Braunwald, and W.S. Colucci. 1985. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside. J. Clin. Invest. 75:643-649.
38. Feldman, M.D., J.D. Alderman, J.M. Aroesty, H.D. Royal, J.J. Ferguson, R.M. Owen, W. Grossman, and R.G. McKay. 1988. Depression of systolic and diastolic myocardial reserve during atrial pacing tachycardia in patients with dilated cardiomyopathy. J. Clin. Invest. 82:1661-1669.